Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032356
Filing Date
2024-08-14
Accepted
2024-08-14 17:00:57
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1774633
2 ex31-1.htm EX-31.1 17302
3 ex32-1.htm EX-32.1 5666
  Complete submission text file 0001493152-24-032356.txt   7740308

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bixt-20240630.xsd EX-101.SCH 50373
5 XBRL CALCULATION FILE bixt-20240630_cal.xml EX-101.CAL 43876
6 XBRL DEFINITION FILE bixt-20240630_def.xml EX-101.DEF 244165
7 XBRL LABEL FILE bixt-20240630_lab.xml EX-101.LAB 361043
8 XBRL PRESENTATION FILE bixt-20240630_pre.xml EX-101.PRE 321893
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1485550
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 241209286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)